CDH11 and pancreatic neoplasm: Using single-cell RNA sequencing (scRNA-seq) we compared the tumor microenvironment of Cdh11-deficient (KPC-Cdh11+/-) and wildtype (KPC-Cdh11+/+) mice with pancreatic tumors and identified immune subpopulations that correlate with decreased tumor burden and improved survival.